Merck Retained Earnings (Accumulated Deficit) 2010-2024 | MKKGY

Merck retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Merck retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $23.023B, a 6.85% increase year-over-year.
  • Merck retained earnings (accumulated deficit) for 2023 were $21.893B, a 12.54% increase from 2022.
  • Merck retained earnings (accumulated deficit) for 2022 were $19.453B, a 8.64% increase from 2021.
  • Merck retained earnings (accumulated deficit) for 2021 were $17.905B, a 26.63% increase from 2020.
Merck Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $21,893
2022 $19,453
2021 $17,905
2020 $14,139
2019 $12,888
2018 $14,792
2017 $11,191
2016 $8,907
2015 $7,795
2014 $8,640
2013 $7,342
2012 $6,094
2011 $12,080
2010 $
2009 $
Merck Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $23,023
2024-03-31 $22,833
2023-12-31 $21,893
2023-09-30 $22,542
2023-06-30 $21,546
2023-03-31 $20,663
2022-12-31 $19,453
2022-09-30 $18,961
2022-06-30 $19,172
2022-03-31 $18,460
2021-12-31 $17,905
2021-09-30 $17,635
2021-06-30 $17,030
2021-03-31 $16,289
2020-12-31 $14,139
2020-09-30 $14,707
2020-06-30 $12,941
2020-03-31 $13,214
2019-12-31 $12,888
2019-09-30 $12,581
2019-06-30 $12,825
2019-03-31 $14,441
2018-12-31 $14,792
2018-09-30 $12,448
2018-06-30 $1,616
2018-03-31 $12,624
2017-12-31 $11,191
2017-09-30 $11,143
2017-06-30 $9,719
2017-03-31 $9,133
2016-12-31 $8,907
2016-09-30 $9,206
2016-06-30 $8,802
2016-03-31 $8,402
2015-12-31 $7,795
2015-09-30 $8,189
2015-06-30 $7,739
2015-03-31 $7,657
2014-12-31 $8,640
2014-09-30 $8,813
2014-06-30 $8,783
2014-03-31 $7,837
2013-12-31 $7,342
2013-09-30 $6,884
2013-06-30 $6,416
2013-03-31 $6,387
2012-12-31 $6,094
2012-09-30 $10,863
2012-06-30 $11,131
2012-03-31
2011-12-31 $12,080
2011-09-30
2011-06-30 $12,215
2011-03-31
2010-12-31
2010-09-30 $12,781
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00